Our new challenge
to visualize people's health
-Betting on the potential of proteins-

Many people think there's just nothing they can do about getting sick or injured, right?

For people with a busy everyday life, most of the ways they maintain and improve their health conditions involve treating symptoms.

Judging people's health status with greater simplicity and speed.
The challenge of healthcare today is judging whether or not you are healthy right now.

Therefore, we focused on the potential of proteins.
aiwell is convinced that the future of societal health can be realized through proteins, which are responsible for changes within humans.

Together with AI Proteomics, towards the realization of futuristic societal health.

For Japan, which struggles with recognition of its research and development, we hope that our attempts at tackling these challenges will change the future of the world.


Our mission is to eliminate presymptomatic illnesses and make sure people are always healthy.


To enhance national mentality towards health care,
and to contribute to societal development both domestically and internationally.
To maintain a foundation for the next generation, and to constantly bring the future into reality.


My thinking is based on the desire to help others
and a desire to make the world a better place.

In the future, the aging of our society will progress, increasing the burden of medical expenses.
I personally spoke with various regional administration officials during disaster reconstruction efforts,and through those discussions I sensed that these regions' approach towards presymptomatic diseases hadn't progressed. In contrast to the budgets of large cities,regions with limited budgets are truly limited in what they can accomplish.
In Japan's soccer world as well, some soccer teams receive blood testing at affiliated hospitals, but teams on a budget are limited in this respect.
But blood microsampling saves the trouble of having to visit a hospital, and can be used for performing blood testing on a tight budget. Furthermore,AI Proteomics can check and improve health even more simply than blood microsampling.
The technology that aiwell is aiming to bring into practical usage would allow us to approach presymptomatic illnesses and improve our own health-- an arrangement that I feel is truly wonderful.


If proteins can be comprehensively
visualized and compared,
a person's health status can be understood

Our bodies are made up of many cells, and proteins are the star of the show when it comes to how these cells work-- they are the 'molecular machinery' of cells, and are in charge of all kinds of jobs.
Genes are referred to as the 'blueprints of the body', but that's because genes are the blueprints for proteins. But we can't always tell what's happening just by looking at the blueprints (genes). To deal with that, by investigating entire cells to see what kinds of proteins are created inside cells, and also what switches them 'on' and 'off', we can suddenly understand everything that's happening within the human body.
Let's compare proteins to various machines, and an individual human to a society. Assorted machines are made according to various blueprints as the time calls for them, but if you happened upon a mass of submarines and tanks in the middle of a city, at that moment you could judge that this is a society at war. However, once the war is over, bulldozers and trucks will eventually become visible, and you can then determine that the society is in the process of rebuilding. In other words, the types and states (at-rest or activated) of the machines supporting a society change according to the circumstances at hand, and by looking at the types and conditions of the active machines, you can ascertain the current state of that society. The human body is the same way.
In the same way, the types and states of the proteins that exist within the body are constantly shifting in accordance with bodily conditions, and also, if we now look at the status of all those proteins, we instantly understand the present status of the body.
Supposing you were able to capture all the states of the proteins in the human body all in one image, this image would let you know about the body's status. Also, changes in health would be made obvious by visually comparing those images with the past, present, and future. Furthermore, because proteins support not only humans but all living organisms, this (the "comprehensive visualization of structural protein states") can be applied to the health conditions of all living things.

Proprietary organism evaluation technology
realized through the cooperation of industry and academia
About "AI Proteomics",which allows for the visualization of health

Proteomics images of various organs

The comprehensive and large-scale study of the states of all the proteins existing in the body is referred to as "proteomics."
 Two-dimensional Electrophoresis is one type of proteomics technology, an imaging technique that creates a single image of the states of the proteins within an organism. Since it was discovered 30 years that it clarifies the structure of DNA (the 'true form' of genes), and based on the data stored therein, that proteins are created within an organism in response to situations at various times, this has been said to be the 'ultimate' method of organism analysis. However, up until now these images have been simple and could not be obtained in a short time period, and for a long time this technology was only used in some fields of research and cutting-edge medical care.
 Recently however, the Tokyo Institute of Technology succeeded in developing technology to easily obtain images, and furthermore they also succeeded in AI-based evaluations (therefore, "AI proteomics") of the large amount of images obtained via this technology (big data.)
 If this technology can be put to use, theoretically speaking, and as long as we can prepare data for AIs to learn from, not only will detection of illnesses at extremely early stages become possible, everyday lifestyle health management as well as quality control of not only humans but livestock and vegetation will also become possible.

Founding of the aiwell AI Proteomics Collaborative Research Center

As of 05 April 2019, we founded the "aiwell AI Proteomics Collaborative Research Center" on the Tokyo Institute of Technology's campus, with Tokyo Institute of Technology Dept. of Life Science and Technology Associate Professor Nobuhiro Hayashi as the field manager. As part of our business plan to further generalize AI Proteomics technology and expand into various industries, we are proceeding with practical applications of "AI Proteomics", not only in humans but including livestock etc. as well.

Field Manager
Nobuhiro Hayashi (Tokyo Institute of Technology, Dept. of Life Science and Technology Associate Professor)
Building 6, Midorigaoka, Ookayama Campus, Tokyo Institute of Technology
Research Contributions
Tokyo Institute of Technology: All research and application of AI Proteomicsaiwell

aiwell Inc.:

Collection of AI Proteomics samples, and the establishment of blood microsampling operational flow/testing methods suited to practical application

Tokyo Institute of Technology

Tokyo Institute of Technology
Dept. of Life Science and Technology
Associate Professor
Nobuhiro Hayashi

The realization of a sustainable
societal health via high-quality databanks

With AI Proteomics technology, as AI learning progresses, we'll be able to understand all kinds of health conditions. For that reason, we must have the AI learn from protein image data from a variety of conditions.
As such, aiwell associates with numerous overseas institutions such as biobanks in order to receive blood proteins. Also, through the sales of blood microsampling kits, aiwell is also capable of acquiring data from individuals.
he provided protein data is securely stored in a single storage location, and by sharing it with various business operators such as hospitals and manufacturers, we are aiming for the construction of a system by which we can provide beneficial services for our future users, so they can have a constant understanding of their personal health status, and be capable of receiving early-stage treatment.Through such a cycle, the realization of sustainable societal health can be expected.


aiwell Inc.
Hiroyuki Mabuchi
Kouzimachi, BASE, THE, 9-3, Nibancho, Chiyoda Ku, Tokyo To, 102-0084, Japan